Commission Directive 2008/85/EC of 5 September 2008 amending Directive 98/8/EC of the European Parliament and of the Council to include thiabendazole as an active substance in Annex I thereto
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement, but no longer in force in the Agreement Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
135/2009 In force in the EEA
No Legal documents
Commission Directive 2008/85/EC of 5 September 2008 amending Directive 98/8/EC of the European Parliament and of the Council to include thiabendazole as an active substance in Annex I thereto
Richtlinie 2008/85/EG der Kommission vom 5. September 2008 zur Änderung der Richtlinie 98/8/EG des Europäischen Parlaments und des Rates zwecks Aufnahme des Wirkstoffs Thiabendazol in Anhang I
Kommisjonsdirektiv 2008/85/EF av 5. september 2008 om endring av europaparlaments- og rådsdirektiv 98/8/EF med hensyn til oppføring av tiabendazol som et aktivt stoff i vedlegg I
History
05.12.2009
Adopted JCD confirmed entry into force date
05.12.2009
Compliance date in the EEA
04.12.2009
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
15.10.2009
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
05.09.2008
Adoption date in the EU
16.10.2008
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.